Tobacco Status Project: Social Media Intervention for Young Adult Smokers

N/ACompletedNCT02207036

University of California, San Francisco501 enrolled

Overview

This randomized clinical trial will test the efficacy of a Facebook intervention based on the Transtheoretical Model (Prochaska and DiClemente) and US Public Health Service Clinical Practice Guidelines with young adults who smoke cigarettes who are age 18 to 25 (N=480).

Participants will be randomized to one of two conditions: (1) a Facebook-delivered intervention tailored to readiness to quit smoking; or (2) the control condition (referral to the Smokefree.gov website). The intervention will include 12 weeks of Facebook-based messages and activities tailored to participants' stage of change. Assessments will occur at baseline, 3, 6, and 12 months follow-up. Assessments will include measures on smoking patterns and thoughts about abstinence. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva cotinine test kits that will be mailed to participants.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

501

Conditions

Smoking

Interventions

Facebook interventionBEHAVIORAL

90 days of Facebook messaging, weekly Ask the Doctor sessions

Smokefree.govBEHAVIORAL

referral to the NCI Smokefree.gov website

Eligibility

Sex: ALLMin age: 18 YearsMax age: 25 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * ages 18-25 years old * english literate * have access to Smartphone or computer with camera * indicate they go on Facebook "most" (≥ 4) days per week * have smoked ≥100 cigarettes in their lives and currently smoke at least 1 cigarette per day on 3 or more days of the week Exclusion Criteria: * do not read English * younger than 18 or older than 25 years of age * do not have access to a Smartphone or computer with a camera * only go on Facebook 3 or fewer days a week * have smoked less than 100 cigarettes in their lifetime or do not currently smoke at least 1 cigarette per day on 3 or more days of the week

Locations (1)

University of California San Francisco Department of Psychiatry

San Francisco, California, United States

Outcomes

Primary Outcomes

7-day point prevalence abstinence at 3 months

Reports of no smoking in the 7 days prior to the 3 month assessment. Biochemical verification of abstinence will also be recorded.

Time frame: 3 months post baseline

7-day point prevalence abstinence at 6 months

Reports of no smoking in the 7 days prior to the 6 month assessment. Biochemical verification of abstinence will also be recorded.

Time frame: 6 months post baseline

7-day point prevalence abstinence at 12 months

Reports of no smoking in the 7 days prior to the 12 month assessment. Biochemical verification of abstinence will also be recorded.

Time frame: 12 months post baseline

Secondary Outcomes

Reduction in cigarettes smoked by at least 50% between Baseline and each follow-up timepoint

Reduction will be assessed at 3, 6, and 12 month follow-ups.

Time frame: 3, 6, and 12 months post baseline

Quit attempts

Quit attempt during the follow-up period at 3, 6, and 12 months post-baseline.

Time frame: 3, 6, and 12 month post-baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.